Vault-13

Avidity Partners Management LP

DALLAS, TX · CIK 1791827 · 13F filing filed 2023-08-14

SEC-registered investment adviser since 2020 · limited partnership

As an employer

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

CityCountryPeople
Dallas, TX (main office)United States United Statesabout 5
New York, NYUnited States United States2

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$2.9bn reported value -5.0% vs Q1 2023
93positions
28.1%in top 10
30 new 18 added 43 reduced 20 sold out vs Q1 2023

Holdings, Q2 2023

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 BECTON DICKINSON & CO COM BDX BDX 398,050 $105.1m3.67% 3.67% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 288.0k, Q2 2023 398.1k +110.0k +110,050 38.2%
2 KARUNA THERAPEUTICS INC COM COM 442,200 $95.9m3.35% 3.35% AddedShares held: Q3 2022 431.8k, Q4 2022 299.0k, Q1 2023 403.8k, Q2 2023 442.2k +38.4k +38,400 9.5%
3 JAZZ PHARMACEUTICALS PLC SHS USD JAZZ JAZZ 702,778 $87.1m3.04% 3.04% AddedShares held: Q3 2022 318.3k, Q4 2022 727.5k, Q1 2023 677.9k, Q2 2023 702.8k +24.9k +24,878 3.7%
4 GE HEALTHCARE TECHNOLOGIES I COMMON STOCK GEHC GEHC 1,045,400 $84.9m2.97% 2.97% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 1.0m
5 TENET HEALTHCARE CORP COM NEW THC THC 990,500 $80.6m2.82% 2.82% ReducedShares held: Q3 2022 0, Q4 2022 717.3k, Q1 2023 1.5m, Q2 2023 990.5k -481.5k -481,500 -32.7%
6 ARGENX SE SPONSORED ADR ARGX ARGX 184,300 $71.8m2.51% 2.51% ReducedShares held: Q3 2022 491.8k, Q4 2022 625.0k, Q1 2023 280.7k, Q2 2023 184.3k -96.4k -96,400 -34.3%
7 IDEAYA BIOSCIENCES INC COM IDYA IDYA 2,985,700 $70.2m2.45% 2.45% ReducedShares held: Q3 2022 3.7m, Q4 2022 3.8m, Q1 2023 3.7m, Q2 2023 3.0m -687.7k -687,700 -18.7%
8 SURGERY PARTNERS INC COM SGRY SGRY 1,555,000 $70.0m2.44% 2.44% ReducedShares held: Q3 2022 267.6k, Q4 2022 3.1m, Q1 2023 3.4m, Q2 2023 1.6m -1.8m -1,800,900 -53.7%
9 ABBVIE INC COM ABBV ABBV 518,400 $69.8m2.44% 2.44% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 518.4k
10 ARVINAS INC COM ARVN ARVN 2,773,189 $68.8m2.40% 2.40% ReducedShares held: Q3 2022 4.3m, Q4 2022 5.0m, Q1 2023 4.3m, Q2 2023 2.8m -1.5m -1,500,711 -35.1%
11 ZENTALIS PHARMACEUTICALS INC COM ZNTL ZNTL 2,334,000 $65.8m2.30% 2.30% ReducedShares held: Q3 2022 4.2m, Q4 2022 5.2m, Q1 2023 2.9m, Q2 2023 2.3m -595.3k -595,300 -20.3%
12 NEUROCRINE BIOSCIENCES INC COM NBIX NBIX 665,316 $62.7m2.19% 2.19% ReducedShares held: Q3 2022 1.9m, Q4 2022 1.8m, Q1 2023 815.7k, Q2 2023 665.3k -150.4k -150,384 -18.4%
13 ELI LILLY & CO COM LLY LLY 133,000 $62.4m2.18% 2.18% NewShares held: Q3 2022 1.0m, Q4 2022 217.0k, Q1 2023 0, Q2 2023 133.0k
14 SYNDAX PHARMACEUTICALS INC COM SNDX SNDX 2,872,000 $60.1m2.10% 2.10% ReducedShares held: Q3 2022 5.6m, Q4 2022 5.9m, Q1 2023 3.9m, Q2 2023 2.9m -993.3k -993,300 -25.7%
15 UNIVERSAL HLTH SVCS INC CL B UHS UHS 370,100 $58.4m2.04% 2.04% ReducedShares held: Q3 2022 0, Q4 2022 825.6k, Q1 2023 670.0k, Q2 2023 370.1k -299.9k -299,900 -44.8%
16 BIO RAD LABS INC CL A BIO BIO 152,600 $57.9m2.02% 2.02% ReducedShares held: Q3 2022 144.8k, Q4 2022 92.2k, Q1 2023 221.5k, Q2 2023 152.6k -68.9k -68,900 -31.1%
17 CENCORA INC COM COR COR 300,000 $57.7m2.02% 2.02% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 126.6k, Q2 2023 300.0k +173.4k +173,400 137.0%
18 PACIFIC BIOSCIENCES CALIF IN COM PACB PACB 4,337,400 $57.7m2.01% 2.01% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 3.8m, Q2 2023 4.3m +524.8k +524,800 13.8%
19 LEGEND BIOTECH CORP SPONSORED ADS LEGN LEGN 798,900 $55.1m1.93% 1.93% ReducedShares held: Q3 2022 0, Q4 2022 970.0k, Q1 2023 1.1m, Q2 2023 798.9k -321.6k -321,600 -28.7%
20 BIOGEN INC COM BIIB BIIB 174,000 $49.6m1.73% 1.73% AddedShares held: Q3 2022 600.0k, Q4 2022 0, Q1 2023 128.8k, Q2 2023 174.0k +45.2k +45,200 35.1%
21 AKERO THERAPEUTICS INC COM AKRO AKRO 1,025,000 $47.9m1.67% 1.67% ReducedShares held: Q3 2022 3.1m, Q4 2022 3.8m, Q1 2023 2.4m, Q2 2023 1.0m -1.4m -1,422,000 -58.1%
22 CUREVAC N V COM CVAC CVAC 4,300,000 $44.8m1.56% 1.56% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 3.5m, Q2 2023 4.3m +750.0k +750,000 21.1%
23 ACADIA HEALTHCARE COMPANY IN COM ACHC ACHC 550,000 $43.8m1.53% 1.53% ReducedShares held: Q3 2022 1.4m, Q4 2022 1.2m, Q1 2023 1.2m, Q2 2023 550.0k -615.3k -615,300 -52.8%
24 VAXCYTE INC COM PCVX PCVX 875,000 $43.7m1.53% 1.53% AddedShares held: Q3 2022 628.7k, Q4 2022 1.6m, Q1 2023 510.0k, Q2 2023 875.0k +365.0k +365,000 71.6%
25 MCKESSON CORP COM MCK MCK 101,200 $43.2m1.51% 1.51% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 101.2k
26 APELLIS PHARMACEUTICALS INC COM APLS APLS 468,700 $42.7m1.49% 1.49% NewShares held: Q3 2022 844.0k, Q4 2022 0, Q1 2023 0, Q2 2023 468.7k
27 BOSTON SCIENTIFIC CORP COM BSX BSX 785,700 $42.5m1.48% 1.48% ReducedShares held: Q3 2022 2.5m, Q4 2022 3.3m, Q1 2023 850.0k, Q2 2023 785.7k -64.3k -64,300 -7.6%
28 ULTRAGENYX PHARMACEUTICAL IN COM RARE RARE 900,700 $41.5m1.45% 1.45% ReducedShares held: Q3 2022 2.1m, Q4 2022 3.0m, Q1 2023 2.1m, Q2 2023 900.7k -1.2m -1,226,200 -57.6%
29 PFIZER INC COM PFE PFE 1,117,467 $41.0m1.43% 1.43% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 1.1m
30 IMMUNOVANT INC COM IMVT IMVT 2,085,000 $39.6m1.38% 1.38% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 1.0m, Q2 2023 2.1m +1.0m +1,042,000 99.9%
31 AXSOME THERAPEUTICS INC COM AXSM AXSM 545,000 $39.2m1.37% 1.37% ReducedShares held: Q3 2022 1.5m, Q4 2022 670.0k, Q1 2023 619.2k, Q2 2023 545.0k -74.2k -74,200 -12.0%
32 IMMUNOGEN INC COM IMGN IMGN 1,997,800 $37.7m1.32% 1.32% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 2.0m
33 ZOETIS INC CL A ZTS ZTS 217,000 $37.4m1.31% 1.31% ReducedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 407.5k, Q2 2023 217.0k -190.5k -190,500 -46.8%
34 PROTHENA CORP PLC SHS PRTA PRTA 535,000 $36.5m1.28% 1.28% ReducedShares held: Q3 2022 2.0m, Q4 2022 3.0m, Q1 2023 1.1m, Q2 2023 535.0k -533.2k -533,200 -49.9%
35 VIR BIOTECHNOLOGY INC COM VIR VIR 1,425,000 $35.0m1.22% 1.22% ReducedShares held: Q3 2022 0, Q4 2022 850.0k, Q1 2023 1.6m, Q2 2023 1.4m -215.2k -215,200 -13.1%
36 IMMUNOCORE HLDGS PLC ADS IMCR IMCR 575,000 $34.5m1.20% 1.20% ReducedShares held: Q3 2022 2.1m, Q4 2022 1.2m, Q1 2023 769.8k, Q2 2023 575.0k -194.8k -194,800 -25.3%
37 SAREPTA THERAPEUTICS INC COM SRPT SRPT 297,500 $34.1m1.19% 1.19% ReducedShares held: Q3 2022 948.2k, Q4 2022 1.1m, Q1 2023 416.0k, Q2 2023 297.5k -118.5k -118,500 -28.5%
38 ARROWHEAD PHARMACEUTICALS IN COM ARWR ARWR 925,000 $33.0m1.15% 1.15% ReducedShares held: Q3 2022 1.3m, Q4 2022 1.4m, Q1 2023 1.7m, Q2 2023 925.0k -816.3k -816,300 -46.9%
39 BIOHAVEN LTD COM BHVN BHVN 1,325,000 $31.7m1.11% 1.11% ReducedShares held: Q3 2022 0, Q4 2022 1.5m, Q1 2023 1.5m, Q2 2023 1.3m -162.2k -162,200 -10.9%
40 REVOLUTION MEDICINES INC COM RVMD RVMD 1,075,000 $28.8m1.00% 1.00% ReducedShares held: Q3 2022 2.3m, Q4 2022 2.5m, Q1 2023 1.3m, Q2 2023 1.1m -269.8k -269,800 -20.1%
41 PRIVIA HEALTH GROUP INC COM PRVA PRVA 1,079,806 $28.2m0.98% 0.98% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 1.1m
42 PHATHOM PHARMACEUTICALS INC COM PHAT PHAT 1,949,700 $27.9m0.98% 0.98% ReducedShares held: Q3 2022 1.9m, Q4 2022 1.9m, Q1 2023 2.0m, Q2 2023 1.9m -98.9k -98,900 -4.8%
43 BAXTER INTL INC COM BAX BAX 604,700 $27.6m0.96% 0.96% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 604.7k
44 FUSION PHARMACEUTICALS INC COM COM 5,700,000 $26.6m0.93% 0.93% UnchangedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 5.7m, Q2 2023 5.7m
45 ROCKET PHARMACEUTICALS INC COM RCKT RCKT 1,326,000 $26.3m0.92% 0.92% AddedShares held: Q3 2022 0, Q4 2022 1.5m, Q1 2023 1.2m, Q2 2023 1.3m +81.6k +81,600 6.6%
46 BLUEPRINT MEDICINES CORP COM BPMC BPMC 415,000 $26.2m0.92% 0.92% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 415.0k
47 EDITAS MEDICINE INC COM EDIT EDIT 3,000,000 $24.7m0.86% 0.86% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 3.0m
48 VENTYX BIOSCIENCES INC COM VTYX VTYX 692,500 $22.7m0.79% 0.79% ReducedShares held: Q3 2022 0, Q4 2022 1.3m, Q1 2023 1.9m, Q2 2023 692.5k -1.2m -1,225,300 -63.9%
49 NATERA INC COM NTRA NTRA 432,900 $21.1m0.74% 0.74% AddedShares held: Q3 2022 1.7m, Q4 2022 1.8m, Q1 2023 249.9k, Q2 2023 432.9k +183.0k +183,000 73.2%
50 LANTHEUS HLDGS INC COM LNTH LNTH 245,100 $20.6m0.72% 0.72% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 245.1k
51 MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD MLTX MLTX 400,000 $20.4m0.71% 0.71% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 400.0k
52 VERONA PHARMA PLC SPONSORED ADS VRNA VRNA 954,500 $20.2m0.70% 0.70% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 878.8k, Q2 2023 954.5k +75.7k +75,700 8.6%
53 AMYLYX PHARMACEUTICALS INC COM AMLX AMLX 901,400 $19.4m0.68% 0.68% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 900.0k, Q2 2023 901.4k +1.4k +1,400 0.2%
54 AXONICS INC COM AXNX AXNX 379,700 $19.2m0.67% 0.67% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 379.7k
55 XENON PHARMACEUTICALS INC COM XENE XENE 481,300 $18.5m0.65% 0.65% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 481.3k
56 REGENERON PHARMACEUTICALS COM REGN REGN 24,800 $17.8m0.62% 0.62% ReducedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 119.1k, Q2 2023 24.8k -94.3k -94,300 -79.2%
57 ROIVANT SCIENCES LTD SHS ROIV ROIV 1,687,500 $17.0m0.59% 0.59% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 1.7m
58 PLIANT THERAPEUTICS INC COM PLRX PLRX 916,600 $16.6m0.58% 0.58% ReducedShares held: Q3 2022 2.0m, Q4 2022 2.2m, Q1 2023 2.7m, Q2 2023 916.6k -1.7m -1,748,400 -65.6%
59 VERVE THERAPEUTICS INC COM COM 878,600 $16.5m0.58% 0.58% ReducedShares held: Q3 2022 1.0m, Q4 2022 1.6m, Q1 2023 1.4m, Q2 2023 878.6k -473.1k -473,100 -35.0%
60 INTELLIA THERAPEUTICS INC COM NTLA NTLA 395,855 $16.1m0.56% 0.56% ReducedShares held: Q3 2022 999.1k, Q4 2022 638.2k, Q1 2023 417.0k, Q2 2023 395.9k -21.1k -21,145 -5.1%
61 CEREVEL THERAPEUTICS HLDNG I COM CERE CERE 501,200 $15.9m0.56% 0.56% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 501.2k
62 ACELYRIN INC COM COM 750,000 $15.7m0.55% 0.55% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 750.0k
63 POINT BIOPHARMA GLOBAL INC COM COM 1,671,800 $15.1m0.53% 0.53% ReducedShares held: Q3 2022 2.8m, Q4 2022 2.4m, Q1 2023 2.4m, Q2 2023 1.7m -739.8k -739,800 -30.7%
64 KARYOPHARM THERAPEUTICS INC COM COM 8,370,100 $15.0m0.52% 0.52% ReducedShares held: Q3 2022 0, Q4 2022 9.6m, Q1 2023 9.6m, Q2 2023 8.4m -1.3m -1,263,811 -13.1%
65 KEZAR LIFE SCIENCES INC COM COM 6,080,000 $14.9m0.52% 0.52% ReducedShares held: Q3 2022 5.4m, Q4 2022 6.8m, Q1 2023 6.5m, Q2 2023 6.1m -439.4k -439,400 -6.7%
66 SCHRODINGER INC COM SDGR SDGR 274,900 $13.7m0.48% 0.48% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 274.9k
67 2SEVENTY BIO INC COMMON STOCK TSVT TSVT 1,342,000 $13.6m0.47% 0.47% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 1.3m
68 MINERALYS THERAPEUTICS INC COM MLYS MLYS 766,700 $13.1m0.46% 0.46% ReducedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 1.3m, Q2 2023 766.7k -497.1k -497,100 -39.3%
69 MERSANA THERAPEUTICS INC COM COM 3,790,000 $12.5m0.44% 0.44% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 3.4m, Q2 2023 3.8m +356.8k +356,767 10.4%
70 CARIBOU BIOSCIENCES INC COM CRBU CRBU 2,758,600 $11.7m0.41% 0.41% UnchangedShares held: Q3 2022 3.2m, Q4 2022 2.9m, Q1 2023 2.8m, Q2 2023 2.8m
71 NANOSTRING TECHNOLOGIES INC COM NSTG NSTG 2,700,400 $10.9m0.38% 0.38% AddedShares held: Q3 2022 698.2k, Q4 2022 2.1m, Q1 2023 2.2m, Q2 2023 2.7m +483.4k +483,400 21.8%
72 ALPINE IMMUNE SCIENCES INC COM NVLS NVLS 1,058,500 $10.9m0.38% 0.38% AddedShares held: Q3 2022 998.6k, Q4 2022 1.0m, Q1 2023 989.5k, Q2 2023 1.1m +69.0k +69,000 7.0%
73 INARI MED INC COM NARI NARI 175,000 $10.2m0.36% 0.36% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 175.0k
74 89BIO INC COM ETNB ETNB 526,376 $10.0m0.35% 0.35% ReducedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 1.8m, Q2 2023 526.4k -1.3m -1,316,600 -71.4%
75 AC IMMUNE SA SHS ACIU ACIU 2,903,278 $8.6m0.30% 0.30% AddedShares held: Q3 2022 274.9k, Q4 2022 325.4k, Q1 2023 325.4k, Q2 2023 2.9m +2.6m +2,577,878 792.2%
76 DENALI THERAPEUTICS INC COM DNLI DNLI 282,752 $8.3m0.29% 0.29% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 282.8k
77 COLLEGIUM PHARMACEUTICAL INC COM COLL COLL 354,100 $7.6m0.27% 0.27% ReducedShares held: Q3 2022 0, Q4 2022 37.9k, Q1 2023 385.5k, Q2 2023 354.1k -31.4k -31,400 -8.2%
78 ALPHATEC HLDGS INC COM NEW ATEC ATEC 393,000 $7.1m0.25% 0.25% NewShares held: Q3 2022 1.7m, Q4 2022 0, Q1 2023 0, Q2 2023 393.0k
79 AN2 THERAPEUTICS INC COM ANTX ANTX 657,200 $5.6m0.20% 0.20% ReducedShares held: Q3 2022 742.6k, Q4 2022 743.6k, Q1 2023 723.2k, Q2 2023 657.2k -66.0k -66,000 -9.1%
80 GRITSTONE BIO INC COM GRTS GRTS 2,765,500 $5.4m0.19% 0.19% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 2.8m
81 COMPASS THERAPEUTICS INC COM CMPX CMPX 1,620,200 $5.2m0.18% 0.18% ReducedShares held: Q3 2022 2.0m, Q4 2022 2.0m, Q1 2023 1.8m, Q2 2023 1.6m -204.8k -204,800 -11.2%
82 SCYNEXIS INC COM NEW COM NEW 1,738,734 $5.1m0.18% 0.18% NewShares held: Q3 2022 1.1m, Q4 2022 1.1m, Q1 2023 0, Q2 2023 1.7m
83 SYROS PHARMACEUTICALS INC COM NEW SYRS SYRS 1,464,034 $4.6m0.16% 0.16% AddedShares held: Q3 2022 900.0k, Q4 2022 900.0k, Q1 2023 904.6k, Q2 2023 1.5m +559.4k +559,404 61.8%
84 ALTIMMUNE INC COM NEW ALT ALT 1,174,100 $4.1m0.14% 0.14% ReducedShares held: Q3 2022 2.7m, Q4 2022 4.0m, Q1 2023 1.3m, Q2 2023 1.2m -141.1k -141,100 -10.7%
85 CENTURY THERAPEUTICS INC COM IPSC IPSC 1,110,900 $3.5m0.12% 0.12% ReducedShares held: Q3 2022 1.3m, Q4 2022 1.3m, Q1 2023 1.3m, Q2 2023 1.1m -157.2k -157,200 -12.4%
86 HYPERFINE INC COM CL A HYPR HYPR 1,188,178 $2.6m0.09% 0.09% ReducedShares held: Q3 2022 1.5m, Q4 2022 1.5m, Q1 2023 1.5m, Q2 2023 1.2m -315.6k -315,576 -21.0%
87 SIMULATIONS PLUS INC COM COM 45,900 $2.0m0.07% 0.07% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 45.9k
88 CAREMAX INC COM CL A COM CL A 636,000 $2.0m0.07% 0.07% ReducedShares held: Q3 2022 755.3k, Q4 2022 755.3k, Q1 2023 755.3k, Q2 2023 636.0k -119.3k -119,329 -15.8%
89 BAUSCH HEALTH COS INC COM BHC BHC 215,100 $1.7m0.06% 0.06% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 215.1k
90 STRUCTURE THERAPEUTICS INC SPONSORED ADS GPCR GPCR 37,800 $1.6m0.05% 0.05% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 37.8k
91 EXSCIENTIA PLC ADS EXAI EXAI 127,600 $755.4k0.03% 0.03% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 127.6k
92 ARTERIS INC COM AIP AIP 75,500 $514.9k0.02% 0.02% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 75.5k
93 NUVATION BIO INC *W EXP 07/07/202 NUVB.WS NUVB.WS 90,560 $15.0k0.00% 0.00% ReducedShares held: Q3 2022 100.0k, Q4 2022 100.0k, Q1 2023 100.0k, Q2 2023 90.6k -9.4k -9,439 -9.4%

Sold out since Q1 2023

SecurityTickerShares held beforeValue then
MERCK & CO INC MRK MRK 600,000 $63.8m600.0k shares
IVERIC BIO INC OPHT OPHT 1,869,200 $45.5m1.9m shares
ABBOTT LABS ABT ABT 354,000 $35.8m354.0k shares
BELLUS HEALTH INC NEW BLU BLU 4,553,577 $32.8m4.6m shares
ICON PLC ICLR ICLR 142,900 $30.5m142.9k shares
BIOMARIN PHARMACEUTICAL INC BMRN BMRN 300,575 $29.2m300.6k shares
AVANTOR INC AVTR AVTR 1,125,000 $23.8m1.1m shares
AVIDITY BIOSCIENCES INC RNA RNA 1,265,545 $19.4m1.3m shares
ARCUTIS BIOTHERAPEUTICS INC ARQT ARQT 1,628,500 $17.9m1.6m shares
DEXCOM INC DXCM DXCM 148,000 $17.2m148.0k shares
BRIDGEBIO PHARMA INC BBIO BBIO 1,000,000 $16.6m1.0m shares
TWIST BIOSCIENCE CORP TWST TWST 819,000 $12.4m819.0k shares
CYTOKINETICS INC CYTK CYTK 252,000 $8.9m252.0k shares
KINNATE BIOPHARMA INC KNTE KNTE 1,160,000 $7.2m1.2m shares
GERON CORP GERN GERN 2,128,000 $4.6m2.1m shares
SANGAMO THERAPEUTICS INC SGMOQ SGMOQ 2,470,000 $4.3m2.5m shares
PRAXIS PRECISION MEDICINES I 4,281,700 $3.5m4.3m shares
CYTEIR THERAPEUTICS INC 1,764,100 $3.2m1.8m shares
BIOATLA INC BCAB BCAB 602,500 $1.6m602.5k shares
REUNION NEUROSCIENCE INC 151,098 $104.3k151.1k shares

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
IMMUNIC INC 13G · filed 2026-04-17 9.9% +5.1 pts 13G 2026-04-17
CONTEXT THERAPEUTICS INC CNTX · 13G · filed 2026-05-12 CNTX 8.7%≈ $4.6m -1.2 pts 13G 2026-05-12
PERSPECTIVE THERAPEUTICS INC CATX · 13G · filed 2026-03-10 CATX 5.3%≈ $20.6m +1.1 pts 13G 2026-03-10